BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17053051)

  • 41. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.
    Strober W; Kelsall B; Fuss I; Marth T; Ludviksson B; Ehrhardt R; Neurath M
    Immunol Today; 1997 Feb; 18(2):61-4. PubMed ID: 9057354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
    Becker C; Wirtz S; Blessing M; Pirhonen J; Strand D; Bechthold O; Frick J; Galle PR; Autenrieth I; Neurath MF
    J Clin Invest; 2003 Sep; 112(5):693-706. PubMed ID: 12952918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease.
    Bregenholt S; Claesson MH
    Eur J Immunol; 1998 Jan; 28(1):379-89. PubMed ID: 9485217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis.
    Park JS; Kwok SK; Lim MA; Kim EK; Ryu JG; Kim SM; Oh HJ; Ju JH; Park SH; Kim HY; Cho ML
    Arthritis Rheumatol; 2014 Apr; 66(4):918-29. PubMed ID: 24757144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders.
    Gee K; Guzzo C; Che Mat NF; Ma W; Kumar A
    Inflamm Allergy Drug Targets; 2009 Mar; 8(1):40-52. PubMed ID: 19275692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis.
    Krausz S; Boumans MJ; Gerlag DM; Lufkin J; van Kuijk AW; Bakker A; de Boer M; Lodde BM; Reedquist KA; Jacobson EW; O'Meara M; Tak PP
    Arthritis Rheum; 2012 Jun; 64(6):1750-5. PubMed ID: 22170479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
    Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
    PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling.
    Coon ME; Diegel M; Leshinsky N; Klaus SJ
    J Immunol; 1999 Dec; 163(12):6567-74. PubMed ID: 10586050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization.
    Ha SJ; Kim DJ; Baek KH; Yun YD; Sung YC
    J Immunol; 2004 Jan; 172(1):525-31. PubMed ID: 14688363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse.
    Sugimoto T; Ishikawa Y; Yoshimoto T; Hayashi N; Fujimoto J; Nakanishi K
    J Exp Med; 2004 Feb; 199(4):535-45. PubMed ID: 14970180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells.
    van Seventer JM; Nagai T; van Seventer GA
    J Neuroimmunol; 2002 Dec; 133(1-2):60-71. PubMed ID: 12446009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages.
    Kang BY; Chung SW; Im SY; Choe YK; Kim TS
    Immunology; 1999 Sep; 98(1):98-103. PubMed ID: 10469239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
    Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
    J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.